SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    22 results for

    “MRX1”

    Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from...

    Ananda Pharma, one of the UK’s leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping...

    Amid rising global scrutiny of the wider medical cannabis prescription model, and with markets like France leaning into pharmaceutical-grade regulation,...
    In response to this growing exodus of promising biotech firms, the European Union has proposed a new Biotech Act, as...
    UK-based cannabinoid pharmaceutical company Ananda Pharma has received ethics approval for a Phase 1 clinical study for its lead compound...

    Argent Biopharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”]   Argent Biopharma (previously...

    UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing...

    Hellenic Dynamics Hellenic Dynamics has announced a further delay in the receipt of a long-term €1m loan, which has already...

    Ananda Developments [stock_market_widget type=”chart” template=”line” assets=”ANA.AQ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”]   The Aquis Stock...

    Cannabis Europa – insights from leading cannabis investors Last week saw European cannabis industry leaders flock to London to attend...

    Ananda-Entwicklungen Ananda Developments hat in dieser Woche seinen Bestand um mehr als 5 % erhöht, nachdem ein “Drug Supply Agreement”...

    Ananda Developments Ananda Developments has seen its stock increase over 5% this week after signing a ‘Drug Supply Agreement’ (DSA)...

    Ananda Developments [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”ANA.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”]   Aquis Stock Exchange-listed UK cannabis...

    Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”]   This week Cantourage UK, a subsidiary...

    German Stocks Spike on Passage of Draft Law [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”SBX.DE” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”]...

    The UK’s National Health Service (NHS) Research Ethics Committee this week approved the full-scale rollout of a new clinical trial...

    Ananda Developments Aquis Stock Exchange-listed Ananda Developments has seen its stock jump by nearly 20% over the last week following...